Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Rockefeller University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Rockefeller University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Rockefeller University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
ContraFect Enters into Research Agreement with Rockefeller University 11
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 12
QR Pharma Enters into Research Agreement with Rockefeller University 13
Licensing Agreements 14
Frontier Biotechnologies Enters into Licensing Agreement with Rockefeller University 14
Cerevance Enters into Licensing Agreement with Rockefeller University 15
ContraFect Enters into Licensing Agreement with Rockefeller University for lysine CF-301 16
ContraFect Enters Into Licensing Agreement With Rockefeller University 17
Lodo Therapeutics Enters into Licensing Agreement with Rockefeller University 18
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 19
NeoStem Enters into Licensing Agreement with Rockefeller University for Patented Technologies 21
Rockefeller University – Key Competitors 22
Rockefeller University – Key Employees 23
Rockefeller University – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Oct 31, 2016: Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologies in Major Academic Institutions through Human Proof of Concept 25
Government and Public Interest 27
Nov 02, 2017: Potential new treatment for Fragile X targets one gene to affect many 27
Jul 24, 2017: Researchers develop new method to generate human antibodies 28
Jun 09, 2017: NIH Funds NYC Center for AIDS Research 29
Mar 06, 2017: A new way to reset gene expression in cancer cells shows promise for leukemia treatment 30
Feb 24, 2017: New structural studies reveal workings of a molecular pump that ejects cancer drugs 32
Feb 03, 2017: Atomic-scale view of bacterial proteins offers path to new tuberculosis drugs 33
Dec 06, 2016: Researchers discover a new gatekeeper controlling T cell release into the bloodstream 34
Nov 23, 2016: Study shows low-dose chemotherapy regimens could prevent tumor recurrence in some cancers 35
Sep 29, 2016: Rockefeller University awarded $27 million NIH grant to fund clinical and translational science in Hospital 36
Sep 22, 2016: A compound that stops cells from making protein factories could lead to new antifungal drugs 37
Jul 13, 2016: The Wistar Institute and Partners Receive Nearly $23 Million from NIH to Advance HIV Cure Research 38
May 30, 2016: A combined approach to treating metastatic melanoma 39
Apr 25, 2016: Fisher Center Scientists Discover Pathway That may Lead to Alzheimer’s Disease 40
Mar 01, 2016: New research clarifies how stem cells get activated to produce new hair—and what happens when their regenerative powers wear out 41
Feb 03, 2016: Study reveals how herpes virus tricks the immune system 42
Jan 14, 2016: Signals that make early stem cells identified 43
Product News 45
05/05/2016: Broadly neutralizing antibodies improve immune response; clear HIV reservoirs 45
02/06/2017: Encouraging clinical results for an antibody drug to prevent or treat HIV 46
01/17/2017: Successful antibody trial in HIV-infected individuals 47
Clinical Trials 48
May 06, 2016: Antibody therapy opens door to potential new treatment for HIV 48
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Rockefeller University, Pharmaceuticals & Healthcare, Key Facts 2
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Rockefeller University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Rockefeller University, Deals By Therapy Area, 2011 to YTD 2017 9
Rockefeller University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
ContraFect Enters into Research Agreement with Rockefeller University 11
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 12
QR Pharma Enters into Research Agreement with Rockefeller University 13
Frontier Biotechnologies Enters into Licensing Agreement with Rockefeller University 14
Cerevance Enters into Licensing Agreement with Rockefeller University 15
ContraFect Enters into Licensing Agreement with Rockefeller University for lysine CF-301 16
ContraFect Enters Into Licensing Agreement With Rockefeller University 17
Lodo Therapeutics Enters into Licensing Agreement with Rockefeller University 18
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 19
NeoStem Enters into Licensing Agreement with Rockefeller University for Patented Technologies 21
Rockefeller University, Key Competitors 22
Rockefeller University, Key Employees 23
Rockefeller University, Joint Venture 24